Linking Infectious and Narcology Care (LINC) in Russia: design, intervention and implementation protocol

Natalia Gnatienko, Steve C Han, Evgeny Krupitsky, Elena Blokhina, Carly Bridden, Christine E Chaisson, Debbie M Cheng, Alexander Y Walley, Anita Raj, Jeffrey H Samet, Natalia Gnatienko, Steve C Han, Evgeny Krupitsky, Elena Blokhina, Carly Bridden, Christine E Chaisson, Debbie M Cheng, Alexander Y Walley, Anita Raj, Jeffrey H Samet

Abstract

Background: Russia and Eastern Europe have one of the fastest growing HIV epidemics in the world. While countries in this region have implemented HIV testing within addiction treatment systems, linkage to HIV care from these settings is not yet standard practice. The Linking Infectious and Narcology Care (LINC) intervention utilized peer-led strengths-based case management to motivate HIV-infected patients in addiction treatment to obtain HIV care. This paper describes the protocol of a randomized controlled trial evaluating the effectiveness of the LINC intervention in St. Petersburg, Russia.

Methods/design: Participants (n = 349) were recruited from the inpatient wards at the City Addiction Hospital in St. Petersburg, Russia. After completing a baseline assessment, participants were randomly assigned to receive either the LINC intervention or standard of care. Participants returned for research assessments 6 and 12 months post-baseline. Primary outcomes were assessed via chart review at HIV treatment locations.

Discussion: LINC holds the potential to offer an effective approach to coordinating HIV care for people who inject drugs in Russia. The LINC intervention utilizes existing systems of care in Russia, minimizing adoption of substantial infrastructure for implementation. Trial Registration NCT01612455.

Keywords: HIV treatment; Peer case managers; Russian HIV; Substance use.

Figures

Fig. 1
Fig. 1
CONSORT diagram
Fig. 2
Fig. 2
LINC resource card containing harm reduction information and contact information for the local HIV clinic
Fig. 3
Fig. 3
LINC medical record review flow chart

References

    1. UNAIDS, World Health Organization. AIDS epidemic update. 2009.
    1. World Health Organization. Summary country profile for HIV/AIDS treatment scale-up: Russian Federation. 2005.
    1. Rhodes T, Sarang A, Bobrik A, Bobkov E, Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy. 2004;15:1–16. doi: 10.1016/j.drugpo.2003.09.001.
    1. Cohen J. Late for the epidemic: HIV/AIDS in Eastern Europe. Science. 2010;329(160):162–164.
    1. World Health Organization. Key facts on HIV epidemic in Russian Federation and progress in 2011. 2013.
    1. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010;376:355–366. doi: 10.1016/S0140-6736(10)60832-X.
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS). The gap report. Geneva: UNAIDS. 2014.
    1. UNAIDS. Russian Federation. 2014. . Accessed: 2015-11-06. (Archived by WebCite® at ).
    1. Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD. Understanding delay to medical care for HIV infection: the long-term non-presenter. AIDS. 2001;15:77–85. doi: 10.1097/00002030-200101050-00012.
    1. Center for Disease Control and Prevention. CDC fact sheet: HIV in the United States: Stages of Care. 2012.
    1. Tkatchenko-Schmidt E, Atun R, Wall M, Tobi P, Schmidt J, Renton A. Why do health systems matter? Exploring links between health systems and HIV response: a case study from Russia. Health Policy Plan. 2010;25:283–291. doi: 10.1093/heapol/czq001.
    1. Krupitsky E, Zvartau E, Karandashova G, Horton N, Schoolwerth K, Bryant K, et al. The onset of HIV infection in the Leningrad region of Russia: a focus on drug and alcohol dependence. HIV Med. 2004;5:30–33. doi: 10.1111/j.1468-1293.2004.00182.x.
    1. Sarang A, Rhodes T, Sheon N. Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study. Health Policy Plan. 2013;28:681–691. doi: 10.1093/heapol/czs107.
    1. Bobrova N, Sarang A, Stuikyte R, Lezhentsev K. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview. Int J Drug Policy. 2007;18:313–318. doi: 10.1016/j.drugpo.2007.01.015.
    1. Samet JH, Freedberg KA, Stein MD, Lewis R, Savetsky J, Sullivan L, et al. Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med. 1998;158:734–740. doi: 10.1001/archinte.158.7.734.
    1. Giordano TP, Visnegarwala F, White AC, Jr, Troisi CL, Frankowski RF, Hartman CM, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17:773–783. doi: 10.1080/09540120412331336652.
    1. Horstmann E, Brown J, Islam F, Buck J, Agins BD. Retaining HIV-infected patients in care: where are we? Where do we go from here? Clin Infect Dis. 2010;50:752–761.
    1. U.S. President’s Emergency Plan for AIDS Relief. FY2008: Country Profile Russia. UNAIDS Report on the Global AIDS Epidemic. 2009. . Accessed 20 Nov 2015.
    1. World Health Organization, Department of Mental Health and Substance Abuse, Management of Substance Abuse. Treatment of injecting drug users with HIV/AIDS: promoting access and optimizing service delivery. 2006.
    1. Jürgens R, Csete J, Amon JJ, Baral S, Beyrer C. People who use drugs, HIV, and human rights. The Lancet. 2010;376:475–485. doi: 10.1016/S0140-6736(10)60830-6.
    1. Amirkhanian YA, Kelly JA, Kuznetsova AV, DiFranceisco WJ, Musatov VB, Pirogov DG. People with HIV in HAART-era Russia: transmission risk behavior prevalence, antiretroviral medication-taking, and psychosocial distress. AIDS Behav. 2011;15:767–777. doi: 10.1007/s10461-010-9793-x.
    1. Gardner LI, Metsch LR, Anderson-Mahoney P, Loughlin AM, Del Rio C, Strathdee S, et al. Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS. 2005;19:423–431. doi: 10.1097/01.aids.0000161772.51900.eb.
    1. Bandura A. Social foundations of thought and action. Englewood Cliffs, NJ: Prentice Hall, Inc; 1986.
    1. Zimmerman MA. Psychological empowerment: issues and illustrations. Am J Community Psychol. 1995;23:581–599. doi: 10.1007/BF02506983.
    1. Bandura A. Perceived self-efficacy in the exercise of control over AIDS infection. In: Primary prevention of AIDS: psychological approaches. Thousand Oaks, CA, US: Sage Publications, Inc; 1989. p. 128-141.
    1. National Institute on Drug Abuse: Seek, test, treat and retain initiative. Seek, test, treat and retain: addressing HIV among vulnerable populations. 2013. . Accessed 20 Nov 2015.
    1. Chandler RK, Kahana SY, Fletcher B, Jones D, Finger MS, Aklin WM, et al. Data collection and harmonization in HIV research: the seek, test, treat, and retain initiative at the National Institute on Drug Abuse. Am J Public Health. 2015;105:2416–2422. doi: 10.2105/AJPH.2015.302788.
    1. Samet JH, Raj A, Cheng DM, Blokhina E, Bridden C, Chaisson CE, et al. HERMITAGE—a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers. Addiction. 2015;110:80–90. doi: 10.1111/add.12716.
    1. Samet JH. Russia and human immunodeficiency virus—beyond crime and punishment. Addiction. 2011;106:1883–1885. doi: 10.1111/j.1360-0443.2011.03523.x.
    1. Cohen SM, Hu X, Sweeney P, Johnson AS, Hall HI. HIV viral suppression among persons with varying levels of engagement in HIV medical care, 19 US jurisdictions. J Acquir Immune Defic Syndr. 2014;67:519–527. doi: 10.1097/QAI.0000000000000349.
    1. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr HL, et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J Nerv Ment Dis. 1985;173:412–423. doi: 10.1097/00005053-198507000-00005.
    1. National Institute on Drug Abuse: Seek, Test, Treat and Retain Initiative. HIV/HCV/STI Testing Status and Organizational Testing Practices Questionnaire. 2011. . Accessed 8 Sept 2015.
    1. Cunningham WE, Hays RD, Williams KW, Beck KC, Dixon WJ, Shapiro MF. Access to medical care and health-related quality of life for low-income persons with symptomatic human immunodeficiency virus. Med Care. 1995;33:739–754. doi: 10.1097/00005650-199507000-00009.
    1. Cunningham WE, Andersen RM, Katz MH, Stein MD, Turner BJ, Crystal S, et al. The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care. 1999;37:1270–1281. doi: 10.1097/00005650-199912000-00010.
    1. Kalichman SC, Catz S, Ramachandran B. Barriers to HIV/AIDS treatment and treatment adherence among African-American adults with disadvantaged education. J Natl Med Assoc. 1999;91:439–446.
    1. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36:588–594.
    1. Justice A, Holmes W, Gifford A, Rabeneck L, Zackin R, Sinclair G, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001;54:S77–S90. doi: 10.1016/S0895-4356(01)00449-8.
    1. Wechsberg W. Revised risk behavior assessment, part I and part II. Research Triangle Park: Research Triangle Institute; 1998.
    1. Stein MD, Freedberg KA, Sullivan LM, Savetsky J, Levenson SM, Hingson R, et al. Sexual ethics: disclosure of HIV-positive status to partners. Arch Intern Med. 1998;158:253–257. doi: 10.1001/archinte.158.3.253.
    1. Raj A, Cheng DM, Levison R, Meli S, Samet JH. Sex trade, sexual risk, and nondisclosure of HIV serostatus: findings from HIV-infected persons with a history of alcohol problems. AIDS Behav. 2006;10:149–157. doi: 10.1007/s10461-005-9050-x.
    1. Berger BE, Ferrans CE, Lashley FR. Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale. Res Nurs Health. 2001;24:518–529. doi: 10.1002/nur.10011.
    1. Radloff LS. The CES-D scale a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. doi: 10.1177/014662167700100306.
    1. Chishinga N, Kinyanda E, Weiss HA, Patel V, Ayles H, Seedat S. Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia. BMC Psychiatry. 2011;11:75-244X-11-75.
    1. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory STAI (form Y)(“self-evaluation questionnaire”). Consulting Psychologists Press Inc. 1983.
    1. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI) Br J Clin Psychol. 1992;31(Pt 3):301–306. doi: 10.1111/j.2044-8260.1992.tb00997.x.
    1. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x.
    1. Meneses-Gaya ICD, Zuardi AW, Loureiro SR, Crippa JADS. Psychometric properties of the Fagerström test for nicotine dependence. Jornal Brasileiro de Pneumologia. 2009;35:73–82. doi: 10.1590/S1806-37132009000100011.
    1. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: the alcohol use disorders identification test guidelines for use in primary care: World Health Organization. Geneva: Switzerland; 2001.
    1. Broome KM, Knight K, Joe GW, Simpson DD. Evaluating the drug-abusing probationer clinical interview versus self-administered assessment. Crim Justice Behav. 1996;23:593–606. doi: 10.1177/0093854896023004005.
    1. Knight K, Simpson DD, Morey JT. An evaluation of the TCU drug screen. Washington, DC: National Institute of Justice, Office of Justice Programs, US Department of Justice. 2002.
    1. Weatherby NL, Needle R, Cesari H, Booth R, McCoy CB, Watters JK, et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plann. 1994;17:347–355. doi: 10.1016/0149-7189(94)90035-3.
    1. Needle R, Fisher DG, Weatherby N, Chitwood D, Brown B, Cesari H, et al. Reliability of self-reported HIV risk behaviors of drug users. Psychol Addict Behav. 1995;9:242. doi: 10.1037/0893-164X.9.4.242.
    1. Britton PC, Bohnert AS, Wines JD, Conner KR. A procedure that differentiates unintentional from intentional overdose in opioid abusers. Addict Behav. 2012;37:127–130. doi: 10.1016/j.addbeh.2011.08.006.
    1. Coates J, Swindale A, Bilinsky P. Household Food Insecurity Access Scale (HFIAS) for measurement of food access: indicator guide. Washington, DC: Food and Nutrition Technical Assistance Project, Academy for Educational Development; 2007.
    1. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51:768–774. doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>;2-1.
    1. Fleishman JA, Sherbourne CD, Crystal S, Collins RL, Marshall GN, Kelly M, et al. Coping, conflictual social interactions, social support, and mood among HIV-infected persons. Am J Community Psychol. 2000;28:421–453. doi: 10.1023/A:1005132430171.
    1. Booth RE, Kennedy J, Brewster T, Semerik O. Drug injectors and dealers in Odessa. Ukraine. J Psychoactive Drugs. 2003;35:419–426. doi: 10.1080/02791072.2003.10400488.
    1. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33:350–357. doi: 10.3109/07853890109002089.
    1. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269–277. doi: 10.1097/00002030-200201250-00017.
    1. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74–79. doi: 10.1310/JFXH-G3X2-EYM6-D6UG.
    1. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee and Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) AIDS Care. 2000;12:255–266. doi: 10.1080/09540120050042891.
    1. Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281:2305–2315. doi: 10.1001/jama.281.24.2305.
    1. Mendelevich V, Zohrabyan L. Barriers to health care services for women who inject illegal drugs. In: International AIDS Society Conference. 2012.
    1. Bird ST, Bogart LM. Perceived race-based and socioeconomic status (SES)-based discrimination in interactions with health care providers. Ethn Dis. 2001;11:554–563.
    1. Demographic and Health Surveys. Calverton: ICF International. . Accessed 21 May 2012.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit